Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Dasatinib is a small molecule inhibitor targeting multiple kinases, including Src family kinases. Src family kinases play a role in cellular signaling cascades, and their inhibition by Dasatinib can influence pathways involved in cell adhesion and migration, potentially impacting Nectin 2 function as part of these processes. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Cisplatin is a platinum-containing chemotherapeutic agent that forms DNA adducts, leading to DNA damage and cell cycle arrest. The cellular responses to DNA damage may indirectly affect Nectin 2 function, as DNA damage response pathways are interconnected with signaling networks regulating cell adhesion and migration. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $246.00 $490.00 $536.00 | 16 | |
Ruxolitinib is a Janus kinase (JAK) inhibitor that modulates cytokine signaling pathways. The JAK-STAT pathway, targeted by Ruxolitinib, is involved in various cellular processes, and its inhibition may influence pathways related to cell adhesion and migration, potentially impacting Nectin 2 function as part of these processes. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Sorafenib is a multi-kinase inhibitor targeting Raf kinase and receptor tyrosine kinases. By modulating these kinases, Sorafenib can influence cellular signaling pathways involved in cell adhesion and migration, potentially impacting Nectin 2 function within these processes. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a phosphoinositide 3-kinase (PI3K) inhibitor. The PI3K-Akt pathway, targeted by Wortmannin, is crucial for various cellular functions, including cell adhesion and migration. Inhibition of PI3K may indirectly affect Nectin 2 function as part of these cellular processes regulated by PI3K signaling. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $179.00 $307.00 $455.00 $924.00 $1689.00 | 7 | |
Blebbistatin is a myosin II inhibitor that affects actin-myosin interactions and inhibits contractile processes in cells. By modulating the cytoskeleton and cellular contractility, Blebbistatin may impact the dynamics of cell adhesion and migration, potentially influencing Nectin 2 function in these processes. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $205.00 $405.00 | 9 | |
Nilotinib is a tyrosine kinase inhibitor targeting BCR-ABL and other kinases. Tyrosine kinases are involved in various cellular processes, including signaling pathways related to cell adhesion and migration. Inhibition of these kinases by Nilotinib may indirectly affect Nectin 2 function within the context of cellular adhesion and migration. | ||||||
PF-562271 | 717907-75-0 | sc-478488 sc-478488A sc-478488B | 5 mg 10 mg 50 mg | $306.00 $465.00 $1102.00 | 3 | |
PF-562271 is a focal adhesion kinase (FAK) inhibitor. FAK plays a crucial role in integrin-mediated signaling and cellular adhesion. Inhibition of FAK by PF-562271 may impact cellular processes involving adhesion and migration, potentially influencing Nectin 2 function as part of these integrin-mediated signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a phosphoinositide 3-kinase (PI3K) inhibitor. As PI3K is involved in various cellular processes, including cell adhesion and migration, its inhibition by LY294002 may indirectly impact Nectin 2 function within the context of these cellular processes regulated by PI3K signaling. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
Tyrphostin B42 (AG-490) is a Janus kinase (JAK) inhibitor. The JAK-STAT pathway, targeted by AG-490, is implicated in cellular processes, and its modulation may influence pathways related to cell adhesion and migration, potentially impacting Nectin 2 function within these processes. |